Total Payments
$6,359
2024 Payments
$428.91
Companies
34
Transactions
210
Medicare Patients
472
Medicare Billing
$93,083
Payment Breakdown by Category
Food & Beverage$5,222 (82.1%)
Education$604.24 (9.5%)
Other$532.72 (8.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,222 | 197 | 82.1% |
| Education | $604.24 | 7 | 9.5% |
| Long term medical supply or device loan | $532.72 | 6 | 8.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $731.58 | 15 | $0 (2024) |
| Incyte Corporation | $708.58 | 29 | $0 (2023) |
| Lilly USA, LLC | $485.01 | 14 | $0 (2022) |
| GlaxoSmithKline, LLC. | $452.08 | 11 | $0 (2022) |
| Merck Sharp & Dohme LLC | $381.04 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $324.54 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $317.51 | 14 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $301.14 | 4 | $0 (2024) |
| Amgen Inc. | $286.97 | 11 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $279.03 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $428.91 | 15 | Deciphera Pharmaceuticals Inc. ($125.00) |
| 2023 | $610.76 | 21 | Novartis Pharmaceuticals Corporation ($264.77) |
| 2022 | $1,354 | 38 | Novartis Pharmaceuticals Corporation ($393.38) |
| 2021 | $3,966 | 136 | Incyte Corporation ($663.77) |
All Payment Transactions
210 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Oncology | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Oncology | ||||||
| 07/23/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: ONCOLOGY | ||||||
| 06/07/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $23.70 | General |
| Category: Oncology | ||||||
| 05/14/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: ONCOLOGY | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Immunology | ||||||
| 04/09/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Immunology | ||||||
| 04/02/2024 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/28/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 01/29/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: ONCOLOGY | ||||||
| 01/22/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Immunology | ||||||
| 11/15/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Oncology | ||||||
| 11/13/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $24.54 | General |
| 11/13/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2023 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Oncology | ||||||
| 11/08/2023 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Oncology | ||||||
| 09/14/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Oncology | ||||||
| 08/21/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Oncology | ||||||
| 08/03/2023 | Bayer Healthcare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Oncology | ||||||
| 08/02/2023 | Incyte Corporation | MONJUVI (Drug), PEMAZYRE | Food and Beverage | Cash or cash equivalent | $25.95 | General |
| Category: Oncology | ||||||
| 06/28/2023 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $35.80 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 281 | 777 | $237,104 | $62,446 |
| 2022 | 3 | 191 | 366 | $111,304 | $30,637 |
Total Patients
472
Total Services
1,143
Medicare Billing
$93,083
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 99 | 255 | $96,900 | $25,118 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 84 | 367 | $93,952 | $24,895 | 26.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 53 | $20,140 | $5,419 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 72 | $18,432 | $4,937 | 26.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 21 | 30 | $7,680 | $2,076 | 27.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 82 | 142 | $53,960 | $14,849 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 75 | 176 | $45,056 | $12,391 | 27.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 34 | 48 | $12,288 | $3,397 | 27.6% |
About Catherine Chan
Catherine Chan is a Ambulatory Care healthcare provider based in San Gabriel, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/22/2020. The National Provider Identifier (NPI) number assigned to this provider is 1821697525.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Catherine Chan has received a total of $6,359 in payments from pharmaceutical and medical device companies, with $428.91 received in 2024. These payments were reported across 210 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,222).
As a Medicare-enrolled provider, Chan has provided services to 472 Medicare beneficiaries, totaling 1,143 services with total Medicare billing of $93,083. Data is available for 2 years (2022–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Ambulatory Care
- Other Specialties Nurse Practitioner
- Location San Gabriel, CA
- Active Since 10/22/2020
- Last Updated 01/14/2022
- Taxonomy Code 163WP2201X
- Entity Type Individual
- NPI Number 1821697525
Products in Payments
- IMBRUVICA (Drug) $421.75
- KISQALI (Drug) $395.83
- KEYTRUDA (Biological) $356.50
- VERZENIO (Drug) $314.36
- MONJUVI (Drug) $312.76
- LUMAKRAS (Drug) $286.97
- ZEJULA (Drug) $275.24
- LYNPARZA (Drug) $197.17
- QINLOCK (Drug) $184.08
- Vitrakvi (Drug) $183.67
- XPOVIO (Drug) $183.33
- BLENREP (Biological) $176.84
- PEMAZYRE (Drug) $172.06
- VYXEOS (Drug) $150.29
- JAKAFI (Drug) $144.81
- Tavalisse (Drug) $128.84
- DEFITELIO (Drug) $126.14
- Lenvima (Drug) $125.24
- IMFINZI (Biological) $108.36
- GILOTRIF (Drug) $106.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.